Tool Market Opportunity Expands with Major Brand Agreements The Australian and New Zealand power and hand tool market is set for a shake-up as Stealth Group Holdings Ltd (ASX:SGI) secures exclusive distribution rights for CAT® Power Tools, Wesco Power Tools, and Harden Hand Tools. This move significantly strengthens Stealth’s exclusive brand strategy, positioning it as
Read More
While most retailers in Australia have been reeling over the past 12 months as macroeconomic pressure has seen consumer spending plummet, tech retailer Harris Technology (ASX: HT8) is on the verge of a major turnaround that has seen a 56% improvement in its results. For the Half Year ended 31 December 2024, Harris Technology reported
Read More
BlueBet Targets Growth with PointsBet Takeover Australia’s online wagering sector is set for a shake-up as BlueBet Holdings Limited (ASX:BBT) has made an offer to acquire PointsBet Holdings Limited in a deal valued between $340 million and $360 million. If successful, the acquisition is expected to generate at least $40 million in annual synergies, positioning
Read More
Despite a challenging macroeconomic environment, Nickel Industries Limited has achieved remarkable milestones in its 12 months ended 31 December 2024 financial year, setting new production records and securing strategic acquisitions that strengthen its position as a leading global nickel producer. The company produced an impressive 135,602 tonnes of finished nickel metal across Nickel Pig Iron
Read More
Expanding Digital Maternity Care with Wearable Technology HeraMED (ASX:HMD), a leader in digital maternity care, has secured a strategic collaboration with global smartwatch giant Garmin (NYSE:GRMN). The agreement enables seamless integration of Garmin’s smartwatch data into HeraMED’s remote pregnancy monitoring platform, HeraCARE—offering expectant mothers and healthcare providers a more comprehensive view of maternal health. HeraMED
Read More
Cosette’s Offer Price Well In Excess of Mayne’s Last Close Mayne Pharma (ASX:MYX) has received a takeover offer from U.S.-based Cosette Pharmaceuticals, Inc., marking a major milestone in the Australian pharmaceutical sector. The agreement, structured as a Scheme of Arrangement, will see Cosette acquire 100% of Mayne Pharma’s shares for $7.40 per share, valuing the
Read More
